Acelrx Pharmaceuticals reported $-6632000 in Operating Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Acelrx Pharmaceuticals ACRX:US USD -6632000 6.94M
Baxter International BAX:US USD -2799000000 3.15B
Becton, Dickinson and BDX:US USD 490M 45M
Cara Therapeutics CARA:US USD -23845000 19.37M
Heron Therapeutics HRTX:US USD -41882000 7.62M
Intra Cellular Therapies ITCI:US USD -55629000 32.29M
Johnson & Johnson JNJ:US USD 5.82B 18M
Pain Therapeutics PTIE:US USD -21345000 1.43M
Pfizer PFE:US USD 9.41B 2.69B
Smiths SMIN:LN GBP -40000000 197M
Teva Pharmaceutical TEVA:IT USD 419M 1.37B
Xeris Pharmaceuticals Inc XERS:US USD -18780000 136K